| Standard treatment group (n = 50) | Anti-TNF agents group (n = 41) | Group-differences | ||||
---|---|---|---|---|---|---|---|
 | Mean (S.D.) | Median | Mean (S.D.) | Median | Mann–Whitney U-test | p-values | Effect sizes (r) |
Arthritis activity: Composite disease activity score | 2.8 (2.5) | 2.00 | 0.65 (1.00) | 0.00 | Z = −4.51 | <0.001 | 0.47 |
Functional disability: CHAQ dis. index | 0.25 (0.37) | 0.10 | 0.30 (0.32) | 0.10 | Z = −0.01 | 0.99 | 0.001 |
Pain intensity: Mean pain diary score | 0.86 (0.88) | 0.60 | 1.03 (1.19) | 0.69 | Z = −0.49 | 0.62 | 0.05 |
 | Number (%) | Number (%) | Chi 2 -test | p-values | Effect sizes (phi) | ||
Patients with no pain reported in the pain diary | 1 (2.0%) | 13 (31.7%) | χ2(1) = 15.27 | <0.001 | 0.41 | ||
Patients with daily pain reported in the pain diary | 12 (24.0%) | 12 (29.3%) | χ2(1) = 0.32 | 0.64 | 0.06 |